533 related articles for article (PubMed ID: 16774924)
1. MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease.
Culbert AA; Skaper SD; Howlett DR; Evans NA; Facci L; Soden PE; Seymour ZM; Guillot F; Gaestel M; Richardson JC
J Biol Chem; 2006 Aug; 281(33):23658-67. PubMed ID: 16774924
[TBL] [Abstract][Full Text] [Related]
2. Intranasal MMI-0100 Attenuates Aβ
Jiang J; Wang Z; Liang X; Nie Y; Chang X; Xue H; Li S; Min C
Front Immunol; 2019; 10():2707. PubMed ID: 31849936
[No Abstract] [Full Text] [Related]
3. MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation--relevance in a mouse model of Parkinson's disease.
Thomas T; Timmer M; Cesnulevicius K; Hitti E; Kotlyarov A; Gaestel M
J Neurochem; 2008 Jun; 105(5):2039-52. PubMed ID: 18298661
[TBL] [Abstract][Full Text] [Related]
4. CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase.
Tan J; Town T; Mori T; Wu Y; Saxe M; Crawford F; Mullan M
J Neurosci; 2000 Oct; 20(20):7587-94. PubMed ID: 11027218
[TBL] [Abstract][Full Text] [Related]
5. Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ).
Bachstetter AD; Xing B; de Almeida L; Dimayuga ER; Watterson DM; Van Eldik LJ
J Neuroinflammation; 2011 Jul; 8():79. PubMed ID: 21733175
[TBL] [Abstract][Full Text] [Related]
6. A Novel and Selective p38 Mitogen-Activated Protein Kinase Inhibitor Attenuates LPS-Induced Neuroinflammation in BV2 Microglia and a Mouse Model.
Gee MS; Kim SW; Kim N; Lee SJ; Oh MS; Jin HK; Bae JS; Inn KS; Kim NJ; Lee JK
Neurochem Res; 2018 Dec; 43(12):2362-2371. PubMed ID: 30327995
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.
Yamamoto M; Kiyota T; Horiba M; Buescher JL; Walsh SM; Gendelman HE; Ikezu T
Am J Pathol; 2007 Feb; 170(2):680-92. PubMed ID: 17255335
[TBL] [Abstract][Full Text] [Related]
8. LRP1 knockdown aggravates Aβ
He Y; Ruganzu JB; Jin H; Peng X; Ji S; Ma Y; Zheng L; Yang W
Exp Cell Res; 2020 Sep; 394(2):112166. PubMed ID: 32645395
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway.
Li Y; Liu L; Barger SW; Griffin WS
J Neurosci; 2003 Mar; 23(5):1605-11. PubMed ID: 12629164
[TBL] [Abstract][Full Text] [Related]
10. α-Iso-cubebene exerts neuroprotective effects in amyloid beta stimulated microglia activation.
Park SY; Park SJ; Park NJ; Joo WH; Lee SJ; Choi YW
Neurosci Lett; 2013 Oct; 555():143-8. PubMed ID: 24090820
[TBL] [Abstract][Full Text] [Related]
11. Neoechinulin A suppresses amyloid-β oligomer-induced microglia activation and thereby protects PC-12 cells from inflammation-mediated toxicity.
Dewapriya P; Li YX; Himaya SW; Pangestuti R; Kim SK
Neurotoxicology; 2013 Mar; 35():30-40. PubMed ID: 23261590
[TBL] [Abstract][Full Text] [Related]
12. Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.
Iwahara N; Hisahara S; Kawamata J; Matsumura A; Yokokawa K; Saito T; Fujikura M; Manabe T; Suzuki H; Matsushita T; Suzuki S; Shimohama S
J Alzheimers Dis; 2017; 55(3):1235-1247. PubMed ID: 27814300
[TBL] [Abstract][Full Text] [Related]
13. Microglial derived tumor necrosis factor-α drives Alzheimer's disease-related neuronal cell cycle events.
Bhaskar K; Maphis N; Xu G; Varvel NH; Kokiko-Cochran ON; Weick JP; Staugaitis SM; Cardona A; Ransohoff RM; Herrup K; Lamb BT
Neurobiol Dis; 2014 Feb; 62():273-85. PubMed ID: 24141019
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade.
Capiralla H; Vingtdeux V; Zhao H; Sankowski R; Al-Abed Y; Davies P; Marambaud P
J Neurochem; 2012 Feb; 120(3):461-72. PubMed ID: 22118570
[TBL] [Abstract][Full Text] [Related]
15. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
16. Amyloid peptide-induced cytokine and chemokine expression in THP-1 monocytes is blocked by small inhibitory RNA duplexes for early growth response-1 messenger RNA.
Giri RK; Selvaraj SK; Kalra VK
J Immunol; 2003 May; 170(10):5281-94. PubMed ID: 12734378
[TBL] [Abstract][Full Text] [Related]
17. Glibenclamide modulates microglial function and attenuates Aβ deposition in 5XFAD mice.
Ju YJ; Kim N; Gee MS; Jeon SH; Lee D; Do J; Ryu JS; Lee JK
Eur J Pharmacol; 2020 Oct; 884():173416. PubMed ID: 32721448
[TBL] [Abstract][Full Text] [Related]
18. MECP2 Increases the Pro-Inflammatory Response of Microglial Cells and Phosphorylation at Serine 423 Regulates Neuronal Gene Expression upon Neuroinflammation.
Wittrahm R; Takalo M; Marttinen M; Kuulasmaa T; Mäkinen P; Kemppainen S; Martiskainen H; Rauramaa T; Pike I; Leinonen V; Natunen T; Haapasalo A; Hiltunen M
Cells; 2021 Apr; 10(4):. PubMed ID: 33918872
[TBL] [Abstract][Full Text] [Related]
19. Donepezil inhibits the amyloid-beta oligomer-induced microglial activation in vitro and in vivo.
Kim HG; Moon M; Choi JG; Park G; Kim AJ; Hur J; Lee KT; Oh MS
Neurotoxicology; 2014 Jan; 40():23-32. PubMed ID: 24189446
[TBL] [Abstract][Full Text] [Related]
20. Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology.
Maphis N; Jiang S; Xu G; Kokiko-Cochran ON; Roy SM; Van Eldik LJ; Watterson DM; Lamb BT; Bhaskar K
Alzheimers Res Ther; 2016 Dec; 8(1):54. PubMed ID: 27974048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
